Angiotensin-converting enzyme therapy and the risk of contrast-induced nephropathy after coronary angiography and percutaneous coronary intervention
Background The effects of angiotensin-converting enzyme inhibitors (ACEI) on the incidence of post-cardiac catheterization contrast-induced nephropathy (CIN) are not well understood. Some studies suggest that ACEI may contribute to CIN,…